期刊论文详细信息
Malta medical journal
Genetic studies of osteoporosis in Malta: a review
Christopher Vidal Angela Xuereb-Anastasi1 
关键词: Osteoporosis;    genetics;    association;    linkage;    TRAF6;    CD44;   
DOI  :  
学科分类:医学(综合)
来源: University of Malta * Medical School
PDF
【 摘 要 】

Osteoporosis is a complex metabolic disease with a strong genetic component which results in a decrease in bone mineral density and deterioration in the microarchitecture of bone, leading to an increased risk of fractures. During the last decade,a number of genetic studies of the Maltese population were performed to determine a potential genetic component which increases the individual’s susceptibility to osteoporosis. Both family and population case-control approaches were used. Linkage analysis using large affected families has identified a region on chromosome 11p12, following which functional studieshave shown that variations within two genes found in that region namely, TRAF6 and CD44, affect geneexpression, and, more specifically, pre-mRNA splicing in the case of CD44. This is the first report of strong suggestive linkage of 11p12 to osteoporosis. Using the candidate gene approach, selected candidate genes,which had been studied in other populations and been found to increase susceptibility to osteoporosis to varying degrees in some of them, included those coding for the vitamin D and oestrogen receptors (VDR &ER1), osteoprotegerin (TNFRSF11B), collagen type 1 (COL1A1), methylenetetrahydrofolate reductase(MTHFR) and lipoprotein receptor related protein (LRP)-5. In the Maltese population, the most significant result showed that a polymorphism in the promoter region of TNFRSF11B, which codes for osteoprotegerin, had a significant effect on bone mineral density, thus increasing the susceptibility to osteoporosis. These studies have shown that variations within three different genes, namely TRAF6, CD44 and TNFRSF11B, all involved in osteoclast biology, might increase the risk of osteoporosis and couldtherefore serve as targets for noveltherapeutic agents.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912010262153ZK.pdf 225KB PDF download
  文献评价指标  
  下载次数:7次 浏览次数:1次